Arteriosclerosis Obliterans
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients with written informed consent Patients with symptomatic arteriosclerosis obliterans Patients with de novo SFA lesions which are optimal to be treated with heparin-bonded covered stents
Exclusion criteria
Exclusion criteria: Patients with previous stent implantation or surgical bypass therapy in the SFA
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Prevalence of thrombus assessed by OFDI at 12-month follow-up | — |
Countries
Japan
Contacts
Hyogo College of Medicine Division of Cardiovascular Medicine and Coronary Heart Disease